Allied Healthcare Product Institutional ownership
What is the Institutional ownership of Allied Healthcare Product?
The Institutional ownership of Allied Healthcare Product Inc. is 9.19%
What is the definition of Institutional ownership?
Institutional Ownership is the amount of a company’s available stock owned by mutual or pension funds, insurance companies, investment firms, endowments or other large entities that manage funds on the behalf of others.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutional ownership of companies in the Health Care sector on NASDAQ compared to Allied Healthcare Product
What does Allied Healthcare Product do?
Allied sells products under various recognized and well-known brand names. When you see any of these brands, you can be assured that the product meets our stringent quality standards.
Companies with institutional ownership similar to Allied Healthcare Product
- AwoX SA has Institutional ownership of 9.17%
- Synaptogenix Inc has Institutional ownership of 9.18%
- Herige has Institutional ownership of 9.18%
- Garware Technical Fibres has Institutional ownership of 9.18%
- The Toronto-Dominion Bank has Institutional ownership of 9.18%
- Frontage has Institutional ownership of 9.19%
- Allied Healthcare Product has Institutional ownership of 9.19%
- Enlivex Therapeutics has Institutional ownership of 9.19%
- Reviva Pharmaceuticals has Institutional ownership of 9.19%
- GAMCO Global Gold Natural Resources & Income Trust has Institutional ownership of 9.19%
- China Binary New Fintech has Institutional ownership of 9.20%
- Novartis AG has Institutional ownership of 9.20%
- U.S. s Income Fund has Institutional ownership of 9.20%